A medication review should be conducted to identify drugs that might contribute to cramping (statins, diuretics)
Therefore, a combination of GLP-1RAs with anticancer drugs could indirectly inhibit the migration, invasion, and growth of tumors by increasing the chemosensitivity of cancer cells
But here's where nutrition becomes critical: when food moves through your system more slowly and your appetite drops by 70-80%, you face three major challenges: The Muscle Loss Problem Research from a 2025 study published in Medical News Today found that proper supervision, strength training, and adequate protein intake are key to keeping muscle while losing weight on GLP-1s
Tirzepatide works with both GLP-1 and GIP receptors at the same time
Weight loss results were observed across all active dose groups in a dose-dependent pattern
[DOI] [PMC free article] [PubMed] [Google Scholar] 41.J-a K, Koh KK, Quon MJ